Related Experiment Video

Updated: Aug 14, 2026

MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent
06:54

MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent

Published on: September 3, 2013

Ornithine decarboxylase activity in prostate and tumor: a feasibility study for PET with L-[5-14C]- and

P H Elsinga1, B J Daemen, K Ishiwata

  • 1Department of Nuclear Medicine, University Hospital, Groningen, The Netherlands.

International Journal of Radiation Applications and Instrumentation. Part B, Nuclear Medicine and Biology
|January 1, 1990
PubMed

More Related Videos

The Bioconjugation and Radiosynthesis of 89Zr-DFO-labeled Antibodies09:29

The Bioconjugation and Radiosynthesis of 89Zr-DFO-labeled Antibodies

Published on: February 12, 2015

Hyperpolarized 13C Metabolic Magnetic Resonance Spectroscopy and Imaging11:43

Hyperpolarized 13C Metabolic Magnetic Resonance Spectroscopy and Imaging

Published on: December 30, 2016

Related Concept Videos

Positron Emission Tomography01:29

Positron Emission Tomography

Positron emission tomography (PET) is a medical imaging technique involving radiopharmaceuticals — substances that emit short-lived radiation. Although the first PET scanner was introduced in 1961, it took 15 more years before radiopharmaceuticals were combined with the technique and revolutionized its potential.
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body being...